In neuroblastoma, N-myc suppresses the expression of major histocompatibility complex (MHC) Class I antigens by reducing the binding of a nuclear factor to the enhancer-A element in the MHC Class I gene promoter. We show here that the p50 subunit of NF-kappaB is part of this complex and that expression of p50 mRNA is suppressed by N-myc. Transfection of a p50 expression vector in neuroblastoma cells that express N-myc at a high level leads to restoration of factor binding to the MHC Class I gene enhancer, restores enhancer activity and leads to re-expression of MHC Class I antigens at the cell surface. These data indicate that the p50 subunit of NF-kappaB is involved in the regulation of MHC Class I antigen expression and that ...
myc genes are best known for causing tumors when overexpressed, but recent studies suggest endogenou...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Amplification of the N-myc oncogene in human neuroblastoma is associated with increased metastatic ...
Amplification of the N-myc gene is correlated with increased metastatic ability of human neuroblasto...
Neuroblastoma cell lines and tumors are characterized by low HLA class I expression. The majority of...
In human neuroblastoma, amplification of the N-myc oncogene is correlated with increased metastatic ...
Downregulation of MHC Class I antigens has been observed in many cancers and usually results from a ...
In neuroblastoma, amplification of the N-myc gene is closely correlated with increased metastatic a...
High‐risk neuroblastomas harbor abundant myeloid cells that suppress antitumor immunity and support ...
<div><p>Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remar...
Major histocompatibility (MHC) class I gene expression is synergistically induced by the cytokines T...
Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remarkable lo...
Neuroblastoma is a cancer of neural crest origin. In one-third of neuroblastoma tumors, the N-myc pr...
It is well established that the nuclear factor-jB (NF-jB) family of transcription factors participat...
myc genes are best known for causing tumors when overexpressed, but recent studies suggest endogenou...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Amplification of the N-myc oncogene in human neuroblastoma is associated with increased metastatic ...
Amplification of the N-myc gene is correlated with increased metastatic ability of human neuroblasto...
Neuroblastoma cell lines and tumors are characterized by low HLA class I expression. The majority of...
In human neuroblastoma, amplification of the N-myc oncogene is correlated with increased metastatic ...
Downregulation of MHC Class I antigens has been observed in many cancers and usually results from a ...
In neuroblastoma, amplification of the N-myc gene is closely correlated with increased metastatic a...
High‐risk neuroblastomas harbor abundant myeloid cells that suppress antitumor immunity and support ...
<div><p>Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remar...
Major histocompatibility (MHC) class I gene expression is synergistically induced by the cytokines T...
Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remarkable lo...
Neuroblastoma is a cancer of neural crest origin. In one-third of neuroblastoma tumors, the N-myc pr...
It is well established that the nuclear factor-jB (NF-jB) family of transcription factors participat...
myc genes are best known for causing tumors when overexpressed, but recent studies suggest endogenou...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...